Abstract:We read the study by Durila et al 1 Durila M, Vajter J, Garaj M, et al. Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: a pilot study. J Heart Lung Transplant. 2020;39:980-982. Google Scholar with interest; however, we seek several clarifications. First, a separate study by Yu et al 2 Yu ES, Jeon MJ, Kang KW, et al. The role of platelet function analyzer-200 in predicting perioperative bleeding risk [e-pub ahead of print]. Korean J Intern Med. doi:10.3904/kjim.2019.112, accessed September 9, 2020. Google Scholar showed that the results of platelet function analyzer 200 (PFA 200) are influenced by various factors, such as the use of aspirin and other non-steroidal anti-inflammatory agents, blood group type, hematocrit and time of blood collection, transfusions, and underlying diseases. The severity of surgery might cause bleeding, which affects collagen–epinephrine and collagen–adenosine diphosphate. The conclusion that the pathology of primary hemostasis detected by the PFA 200 (collagen–epinephrine and collagen–adenosine diphosphate) was specific for the extracorporeal membrane oxygenation (ECMO) phase of surgery is not robust and is subject to confounding bias. 3 Zhang Z Model building strategy for logistic regression: purposeful selection. Ann Transl Med. 2016; 4: 111 Crossref PubMed Scopus (192) Google Scholar Second, a continuous intravenous infusion of low-molecular-weight heparin was used to prevent venous thromboprophylaxis, but without dose described. Piwowarczyk et al 4 Piwowarczyk P, Borys M, Kutnik P, et al. Unfractionated heparin versus subcutaneous nadroparin in adults supported with venovenous extracorporeal membrane oxygenation: a retrospective, multicenter study [e-pub ahead of print]. ASAIO J. doi:10.1097/MAT.0000000000001166, accessed September 9, 2020. Google Scholar compared nadroparin with unfractionated heparin during veno-venous ECMO and found no significant difference in the number of thrombotic and hemorrhagic events. In the paper by Durila et al, 1 Durila M, Vajter J, Garaj M, et al. Acquired primary hemostasis pathology detected by platelet function analyzer 200 seen during extracorporeal membrane oxygenation is sufficient to prevent circuit thrombosis: a pilot study. J Heart Lung Transplant. 2020;39:980-982. Google Scholar even with the use of continuous intravenous infusion of low-molecular-weight heparin, 2 patients suffered thrombotic events. Third, the duration of the ECMO in their work is short (5 ± 3 days). The effect of duration of support on outcomes was not provided because we would suggest that the risk of thrombotic events is lower with a shorter duration of ECMO support. Given these considerations, it is difficult for us to completely agree with the conclusion that the PFA 200 analyzer may be used to prevent circuit thrombosis instead of using unfractionated heparin in patients on prolonged ECMO. We believe that a point-of-care test such as the PFA 200 may assist in adjusting anti-coagulant strategy to potentially reduce the use of unfractionated heparin rather than to prevent circuit thrombosis and obviate the use of unfractionated heparin altogether, especially in patients on prolonged ECMO support.

Hemostatic Alterations During Extracorporeal Membrane Oxygenation in Ovine Veno-Venous and Veno-Arterial Models

Effects of Extracorporeal Membrane Oxygenation on the Coagulation System

Myocardial protection of early extracorporeal membrane oxygenation (ECMO) support for acute myocardial infarction with cardiogenic shock in pigs

Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support

Safety and Efficacy of a Novel Centrifugal Pump and Driving Devices of the OASSIST ECMO System: A Preclinical Evaluation in the Ovine Model

An Ovine Model of Awake Veno-Arterial Extracorporeal Membrane Oxygenation

Superior Vena Cava Drainage Improves Upper Body Oxygenation During Veno-Arterial Extracorporeal Membrane Oxygenation in Sheep

Effect of venovenous extracorporeal membrane oxygenation on the heart in a healthy piglet model

Hemostasis During Extracorporeal Membrane Oxygenation: More Questions

Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study

Assessing the Impact of Total Extracorporeal Circulation on Hemodynamics in an Ovine Fetal Model

The Effect of Venovenous Extra-Corporeal Membrane Oxygenation (ECMO) Therapy on Immune Inflammatory Response of Cerebral Tissues in Porcine Model

Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis

Feasibility and Stability of a Long Term “awake” Extracorporeal Membrane Oxygenation Model in Large Animal

The Effect of Extracorporeal Membrane Oxygenation Therapy on Systemic Oxidative Stress Injury in A Porcine Model

Effect of Veno-Arterial Extracorporeal Membrane Oxygenation Lower-Extremity Cannulation on Intra-Arterial Flow Characteristics, Oxygen Content, and Thrombosis Risk

Neutrophil extracellular traps are increased after extracorporeal membrane oxygenation support initiation and present in thrombus: A preclinical study using sheep as an animal model

Haematological Trends and Transfusion during Adult Extracorporeal Membrane Oxygenation: A Single Centre Study

In-line Hemofiltration Minimized Extracorporeal Membrane Oxygenation-Related Inflammation in a Porcine Model

Exploring the Impact of Extracorporeal Membrane Oxygenation on the Endothelium: A Systematic Review

Clinical Features and Risk Factors Analysis for Hemorrhage in Adults on ECMO